Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 4, 2011, Pages 281-284

  Costa, Alzenira ^a   Gao, Lin ^b,c   Carrillo, Fátima ^b   Cáceres Redondo, María Teresa ^b   Carballo, Manuel ^b   Díaz Martín, Juan ^b   Gómez Garre, Pilar ^b   Sobrino, Francisco ^a   Lucas, Miguel ^a   López Barneo, José ^b,c   Mir, Pablo ^b,c   Pintado, Elizabeth ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Clinical manifestation; FRAXA; FRAXE; Parkinson's disease; Risk factor

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN 2; LEVODOPA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; TRINUCLEOTIDE REPEAT;

AGED; ALLELES; FEMALE; FRAGILE X SYNDROME; HUMANS; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RISK FACTORS; TRINUCLEOTIDE REPEATS;

EID: 79955007791     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.12.013     Document Type: Article

References (12)

1. Sofola O.A., Jin P., Botas J., Nelson D.L. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet 2007, 16:2326-2332.
2. Murray A., Youings S., Dennis N., Latsky L., Linehan P., McKechnie N., et al. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet 1996, 5:727-735.
3. Kraff J., Tang H.T., Cilia R., Canesi M., Pezzoli G., Goldwurm S., et al. Screen for excess FMR1 premutation alleles among males with parkinsonism. Arch Neurol 2007, 64:1002-1006.
4. Cilia R., Kraff J., Canesi M., Pezzoli G., Goldwurm S., Amiri K., et al. Screening for the presence of FMR1 premutation alleles in women with parkinsonism. Arch Neurol 2009, 66:244-249.
5. Loesch D.Z., Khaniani M.S., Slater H.R., Rubio J.P., Bui Q.M., Kotschet K., et al. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin Genet 2009, 76:471-476.
6. Tan E.K., Zhao Y., Puong K.Y., Law H.Y., Chan L.L., Yew K., et al. Expanded FMR1 alleles are rare in idiopathic Parkinson's disease. Neurogenetics 2005, 6:51-52.
7. Toft M., Aasly J., Bisceglio G., Adler C.H., Uitti R.J., Krygowska-Wajs A., et al. Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord 2005, 20:230-233.
8. Deng H., Le W., Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA 2004, 292:1685-1686.
9. Hedrich K., Pramstaller P.P., Stubke K., Hiller A., Kabakci K., Purmann S., et al. Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?. Mov Disord 2005, 20:1060-1062.
10. Kurz M.W., Schlitter A.M., Klenk Y., Mueller T., Larsen J.P., Aarsland D., et al. FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal study. J Geriatr Psychiatry Neurol 2007, 20:89-92.
11. Annesi G., Nicoletti G., Tarantino P., Cutuli N., Annesi F., Marco E.V., et al. FRAXE intermediate alleles are associated with Parkinson's disease. Neurosci Lett 2004, 368:21-24.
12. Youings S.A., Murray A., Dennis N., Ennis S., Lewis C., McKechnie N., et al. FRAXA and FRAXE: the results of a five year survey. J Med Genet 2000, 37:415-421.